“TriLink provides high quality reagents which have contributed to the excellent performance of our eSensor products in the marketplace to date,” said Osmetech Molecular Diagnostics chief operating officer, Pankaj Singhal.
“TriLink is proud to work with Osmetech in the advancement of this important science and rapidly developing commercial opportunity,” said TriLink chief executive officer, Dr. Richard Hogrefe.
Osmetech Molecular Diagnostics is focused on providing cutting-edge, cost-effective molecular diagnostic technologies and tools that enable a broader range of hospitals and laboratories to offer molecular diagnostic services for improved patient care.